Blue Horseshoe Stocks: Options Roundup & More

Morgan Stanley MS – Recap

Morgan Stanley had a solid beat on profits yesterday in its premarket Q3 earnings report, which led us to signal interest for the MS Weekly $43.50 & $44 Calls in our report.

It turned out to be an excellent set of ideas, which each contract making a hundred percent move or better. With the market on the rebound, it was like taking candy from a baby, and we may see more similar activity if we get another strong session as a whole.

The 43.50 Calls ran from a low of 1.32 and reached 2.65 for an intraday gain of 101% while the range on the $44′s was .85-2.20, going down as a single session move of 159%
______

Fresh Options Ideas

SPDR S&P 500 ETF (SPY) - Should the markets be in for another day of recovery after last week’s backslide, we’re going to also be interested in tracking the activity of the SPY Weekly $279-280.50 Calls.

Netflix, Inc. NFLX – We’ll also take advantage of the market resurgence with an idea pertaining to the NFLX chain. We’ll have our eyes on the NFLX Weekly $377.50-385 Calls as well.

Moody’s Co. MCO – Lastly, we like the technical setup of the Moody’s chart, along with its volatility. It may produce some good chances in the  MCO 11/16 $170-180 Calls, so we’re going to throw those on our track list as well.


Extended Watchlist: 
OHGI, ISR, MNGA, SLS,

Blue Horseshoe Stocks: Options Explosion

Big Time Options Success
We included a trio of options ideas in yesterday morning’s premarket report, and with the type of consistent success we have had in the options trading area recently, it should come as no surprise to any of our readers that we scored the hat track.

We’re in the thick of Q2 earnings season, with big name companies reporting left and right. We will continue to milk this cow for as long as possible. Take a look at the single-session gains that were available in yesterday’s watchlist, and read on to get some fresh ideas to close out the week.

AMD Weekly $16.50 & 17 Calls
$16.50 Calls – Range: .49-1.93 – Max Gain: 293%
$17 Calls – Range: .25-1.40 – Max Gain: 460%
Updated Idea: $18-19 Calls

QCOM Weekly $62.50-64 Calls
$45.50 Calls – Range: .20-1.21 – Max Gain: 505%
$46 Calls – Range: .13-.82 – Max Gain: 531%
$45.50 Calls – Range: .10-.50 – Max Gain: 400%
$46 Calls – Range: .06-.27 – Max Gain: 350%

UAA Weekly $21.50-23 Calls
$45.50 Calls – Range: .43-.97 – Max Gain: 126%
$46 Calls – Range: .06-1.00 – Max Gain: 1566%
$45.50 Calls – Range: .14-.71 – Max Gain: 407%
$46 Calls – Range: .05-.57 – Max Gain: 1040%
_________

Fresh Ideas:
Whirlpool Corp WHR 08/03 $129-131 Calls
Chipotle, Inc CMG Weekly $467.50-475 Calls
Yum China Holdings, Inc. YUMC 08/17 $37.50-42.50 Calls


Extended Watchlist:
EXPE, CRMD, ISR, SBS, CHK, MEIP, GST

Incoming search terms:

  • fightdxd
  • UAB6

Blue Horseshoe Stocks: SYMC Bottom-Play & More

Turtle Beach Corp. HEAR

We were very pleased with HEAR on Friday, mentioning the incredible 400% move the stock had made since our initial alert on April 9th, from a low of 2.76 to 13.88.

As it happened, the stock wasn’t done impressing us yet. HEAR made an excellent run on Friday from a daily low of 10.60 to its new high of 18.62. That’s an intraday move of 76%, and an enormous 575% increase over our observed low from last month.


Symantec, Inc. SYMC

We are always on the lookout for potential bottom plays, and Symantec is going to go on our watchlist as such a candidate as we kick off a new trading week.

A sweeping round of analyst downgrades from Piper Jaffray and others, effected a massive selloff in SYMC, and we’re already seeing a start to a rebound this morning with the stock gapping up roughly 5% in the premarket.

We’re going to keep an eye on SYMC Weekly $19.50-21.50 Calls as well, in the event that the stock continues to rebound.


Extended Watchlist:
HUYA, MYO, ISR, NPTN, SEGI, NXPI, REGI, LITE, HTBX

Blue Horseshoe Stocks: AAPL Recap, MDCN News & More

Apple, Inc. AAPL – Options Recap

To start things off this week we want to look back to Friday’s report wherein we suggested that $131 and $132 Weekly Calls would be in play for possible daytrading opportunities, and our assertion was spot-on. The trading range on the $131 Calls was from .63-1.98, which was an overall spike of 214%, while the $132′s jumped from .14 to 1.00; a total increase of 614%

Those ranges, while extremely impressive, only reflect a fraction of the total possible gains for folks with daytrading ability. As you can see on the following chart snapshots of Friday’s intraday activity, these AAPL Calls were both what we commonly refer to as a “Flipper’s Dream”. Not one, but three big swings could have provided major ammunition for top-shelf profits.


Medican Enterprises, Inc. MDCN

MDCN is a marijuana-related stock that we’ve tracked in the past that has cropped up with a noteworthy PR this morning that we think our readers ought to check out.

Additionally, following a huge a huge run in late March, the stock has been under serious consolidation so it also qualifies as a potential bottom play as well. This will definitely be one to keep on our radars this week.


More News Plays
Here are a couple morning gappers with hefty PRs hitting the wires today:

IntelliPharmaCeutics International, Inc. IPCI

Live Person, Inc. LPSN


Extended Watchlist:
PBMD, ISR, CERU, JDST, AEZS

Blue Horseshoe Stocks: Recap of Yesterday’s Huge Session

Our first order of business today will be to go over the wealth of premium gain opportunities contained in yesterday’s premarket report. We had not one, but three of our selections make major moves, not to mention a couple of other modest gainers.

Prima BioMed, Ltd. PBMD

Quickly shooting to the top of our watchlist was PBMD. Its performance was exhilarating to behold as the stock went on an absolute tear from a low of 2.08 on up to 6.48. It marked an epic intraday run which produced total possible gains on the order of 211%

The move occurred on monstrous volume to the tune of nearly 62X the 3-month average, and stemmed largely from some positive results on one of the company’s trial drugs, announced Tuesday. >> READ PR

With the kind of momentum we’ve witnessed building up in just a single session from PBMD, we’re very interested to continue to follow the price action. A significant dip-and-rip scenario could soon present itself.


IsoRay, Inc. ISR

We also tagged ISR in yesterday’s extended watchlist, and it too shot up rapidly with the help of optimistic results from one of its own drug trials. From an early low of 1.86, the stock ran up as high as 3.38, carving out an intraday rip of 82%

This morning, we saw ISR go as high as 4.00 in premarket trading, extending the overnight range on this play to an eyebrow-raising 115%

We’ll certainly be monitoring this stock as we cruise into week’s end. Like PBMD, we’ll be on the lookout for profit-taking to possibly put a dip-and-rip scenario into effect.


Holiday Island Holdings, Inc. HIHI

In our closing thought from yesterday’s report, we called attention to a massive one-third share reduction being enacted by HIHI, and were extremely pleased to have done so. From a low of .0015, the stock broke out to hit .00265; a healthy move totaling 76%

We then saw it pull back into the close, but we’re not finished monitoring the stock by any means. We caught wind of a promotion (in which we are not involved) going out on HIHI this morning, which could provide us with an impeccably-timed boost to extend our profits as we look to take them off the table.


In light of the monumental performances we’ve seen out of news-fueled pharma plays this week, we’ve dug up a few more this morning for us to pin to our watchlists:

Calithera Biosciences, Inc. CALA

Actinium Pharmaceuticals, Inc. ATNM

Ampio Pharmaceuticals, Inc. AMPE


Extended Watchlist:
NSPR, CTP, AVEO